Načítá se...
Cure for thalassemia major – from allogeneic hematopoietic stem cell transplantation to gene therapy
Allogeneic hematopoietic stem cell transplantation has been well established for several decades as gene replacement therapy for patients with thalassemia major, and now offers very high rates of cure for patients who have access to this therapy. Outcomes have improved tremendously over the last dec...
Uloženo v:
| Vydáno v: | Haematologica |
|---|---|
| Hlavní autoři: | , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Ferrata Storti Foundation
2017
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5286930/ https://ncbi.nlm.nih.gov/pubmed/27909215 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3324/haematol.2015.141200 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|